Deglycosylation of mAb by EndoS for Improved Molecular Imaging

Molecular Imaging and Biology

Volumn 17, Issue 2, 2015, Pages 195-203

  Gao, Peng ^a   Pinkston, Kenneth L ^a   Wilganowski, Nathaniel ^a   Robinson, Holly ^a   Azhdarinia, Ali ^a   Zhu, Banghe ^a   Sevick Muraca, Eva M ^a   Harvey, Barrett R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Deglycosylation; EpCAM; mAb imaging agents; Near infrared imaging

Indexed keywords

CELL ADHESION MOLECULE; FC RECEPTOR; FCGR1 PROTEIN, MOUSE; GLYCOSIDASE; MONOCLONAL ANTIBODY; PROTEIN BINDING; TUMOR ANTIGEN; TUMOR-ASSOCIATED ANTIGEN GA733;

ANIMAL; CELL LINE; DISEASE MODEL; GLYCOSYLATION; HUMAN; IMMUNOLOGY; INFLAMMATION; LYMPH NODE; MACROPHAGE; MALE; METABOLISM; MOLECULAR IMAGING; NUDE MOUSE; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SPECTROFLUOROMETRY; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL LINE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GLYCOSIDE HYDROLASES; GLYCOSYLATION; HUMANS; INFLAMMATION; LYMPH NODES; MACROPHAGES; MALE; MICE, NUDE; MOLECULAR IMAGING; PROTEIN BINDING; RECEPTORS, IGG; ROC CURVE; SPECTROMETRY, FLUORESCENCE;

EID: 84939887597     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0781-9     Document Type: Article

References (38)

1. Sampath L, Kwon S, Ke S et al (2007) Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med 48:1501–1510
2. Ogawa M, Regino CA, Seidel J et al (2009) Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconj Chem 20:2177–2184
3. Sano K, Mitsunaga M, Nakajima T et al (2012) In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores. Breast Canc Res 14:R61
4. Pesnel S, Pillon A, Creancier L et al (2012) Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal antibody. PLoS One 7:e30690
5. Heath CH, Deep NL, Beck LN et al (2013) Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol: Head Neck Surg 148:982–990
6. Day KE, Sweeny L, Kulbersh B et al (2013) Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol 15:722–729
7. Zhang Y, Hong H, Engle JW et al (2012) Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol imaging 2:1–13
8. Zhang Y, Hong H, Niu G et al (2012) Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. Molr Pharm 9:3586–3594
9. Xu H, Eck PK, Baidoo KE et al (2009) Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging. Bioorg Med Chem 17:5176–5181
10. Vaccaro C, Zhou J, Ober RJ, Ward ES (2005) Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels. Nat Biotech 23:1283–1288
11. Kaur S, Venktaraman G, Jain M et al (2012) Recent trends in antibody-based oncologic imaging. Canc Lett 315:97–111
12. Olafsen T, Kenanova VE, Wu AM (2006) Tunable pharmacokinetics: modifying the in vivo half-life of antibodies by directed mutagenesis of the Fc fragment. Nat Protoc 1:2048–2060
13. Strohl WR (2009) Optimization of Fc-mediated effector functions of monoclonal antibodies. Curr Opin Biotechnol 20:685–691
14. Hall MA, Pinkston KL, Wilganowski N et al (2012) Comparison of mAbs targeting epithelial cell adhesion molecule for the detection of prostate cancer lymph node metastases with multimodal contrast agents: quantitative small-animal PET/CT and NIRF. J Nucl Med 53:1427–1437
15. Nandakumar KS, Collin M, Olsen A et al (2007) Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol 37:2973–2982
16. Verma A, Ngundi MM, Meade BD et al (2009) Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin Vaccine Immunol 16:1405–1412
17. Zhu B, Wu G, Robinson H et al (2013) Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Mol Imaging Biol 15:560–568
18. Sevick-Muraca EM, Zhu B (2013) The need for performance standards in clinical translation and adoption of fluorescence molecular imaging. Med Phys 40:040402
19. Zhu B, Rasmussen JC, Sevick-Muraca EM (2014) A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see? Med Phys 41:022105
20. Jefferis R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21:11–16
21. Allhorn M, Briceno JG, Baudino L et al (2010) The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis. Blood 115:5080–5088
22. Karsten CM, Kohl J (2012) The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases. Immunobiol 217:1067–1079
23. Weinshank RL, Luster AD, Ravetch JV (1988) Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha. J Exp Med 167:1909–1925
24. Lee IF, van den Elzen P, Tan R, Priatel JJ (2011) NKT cells are required for complete Freund’s adjuvant-mediated protection from autoimmune diabetes. J Immunol 187:2898–2904
25. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT (1984) Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A 81:6851–6855
26. Boulianne GL, Hozumi N, Shulman MJ (1984) Production of functional chimaeric mouse/human antibody. Nature 312:643–646
27. Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323–327
28. Bruggemann M, Spicer C, Buluwela L et al (1991) Human antibody production in transgenic mice: expression from 100 kb of the human IgH locus. Eur J Immunol 21:1323–1326
29. Harvey BR, Georgiou G, Hayhurst A et al (2004) Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Natl Acad Sci U S A 101:9193–9198
30. Harvey BR, Shanafelt AB, Baburina I et al (2006) Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression. J Immunol Methods 308:43–52
31. Krebber A, Bornhauser S, Burmester J et al (1997) Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Immunol Methods 201:35–55
32. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR (1994) Making antibodies by phage display technology. Annu Rev Immunol 12:433–455
33. Vafa O, Gilliland GL, Brezski RJ et al (2014) An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations. Methods 65:114–126
34. Jayagopal A, Russ PK, Haselton FR (2007) Surface engineering of quantum dots for in vivo vascular imaging. Bioconj Chem 18:1424–1433
35. Steplewski Z, Sun LK, Shearman CW et al (1988) Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci U S A 85:4852–4856
36. Mancardi DA, Albanesi M, Jonsson F et al (2013) The high-affinity human IgG receptor FcgammaRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 121:1563–1573
37. Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer. Brit J Can 96:417–423
38. Allhorn M, Olin AI, Nimmerjahn F, Collin M (2008) Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One 3:e1413